ArticleTherapeutic advances in musculoskeletal disease2022

Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data.

Angelo Fassio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.